Report Detail

Technology Global Artificial Intelligence (AI) Partnering 2019 to 2024

  • RnM3589061
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 123 pages
  • |
  • Maia Research
  • |
  • Technology

Global Artificial Intelligence (AI) Partnering 2019 to 2024

Executive Summary

    Chapter 1 Introduction

      Chapter 2 Trends in artificial intelligence dealmaking

      • 2.1. Introduction
      • 2.2. Artificial intelligence partnering over the years
      • 2.3. Most active artificial intelligence dealmakers
      • 2.4. Artificial intelligence partnering by deal type
      • 2.5. Artificial intelligence partnering by therapy area
      • 2.6. Deal terms for artificial intelligence partnering
        • 2.6.1 Artificial intelligence partnering headline values
        • 2.6.2 Artificial intelligence deal upfront payments
        • 2.6.3 Artificial intelligence deal milestone payments
        • 2.6.4 Artificial intelligence royalty rates

      Chapter 3 Leading artificial intelligence deals

      • 3.1. Introduction
      • 3.2. Top artificial intelligence deals by value

      Chapter 4 Most active artificial intelligence dealmakers

      • 4.1. Introduction
      • 4.2. Most active artificial intelligence dealmakers
      • 4.3. Most active artificial intelligence partnering company profiles

      Chapter 5 Artificial intelligence contracts dealmaking directory

      • 5.1. Introduction
      • 5.2. Artificial intelligence contracts dealmaking directory

      Chapter 6 Artificial intelligence dealmaking by technology type

        Chapter 7 Partnering resource center

        • 7.1. Online partnering
        • 8.2. Partnering events
        • 8.3. Further reading on dealmaking

        Appendices

          Appendix 1 Artificial intelligence deals by company A-Z

            Appendix 2 Artificial intelligence deals by stage of development

              Discovery

                Preclinical

                  Phase I

                    Phase II

                      Phase III

                        Regulatory

                          Marketed

                            Formulation

                              Appendix 3 Artificial intelligence deals by deal type

                                Asset purchase

                                  Bigpharma outlicensing

                                    Co-development

                                      Collaborative R&D

                                        Co-market

                                          Co-promotion

                                            CRADA

                                              Cross-licensing

                                                Development

                                                  Distribution

                                                    Evaluation

                                                      Grant

                                                        Joint venture

                                                          Licensing

                                                            Manufacturing 

                                                              Marketing

                                                                Option

                                                                  Research

                                                                    Spin out

                                                                      Sub-license

                                                                        Supply

                                                                          Technology transfer

                                                                            Appendix 4 Artificial intelligence deals by therapy area

                                                                              Cardiovascular

                                                                                Central Nervous System

                                                                                  Genetic disorders

                                                                                    Hematology

                                                                                      Immunology

                                                                                        Infectives

                                                                                          Metabolic

                                                                                            Musculoskeletal

                                                                                              Obstetrics

                                                                                                Oncology

                                                                                                  Ophthalmics

                                                                                                    Orphan disease

                                                                                                      Pediatrics

                                                                                                        Respiratory

                                                                                                          Appendix 5 Deal type definitions

                                                                                                            About Wildwood Ventures

                                                                                                              Current Partnering

                                                                                                                Current Agreements

                                                                                                                  Recent report titles from Current Partnering

                                                                                                                    Table of figures

                                                                                                                      Figure 1: Artificial intelligence partnering since 2014

                                                                                                                        Figure 2: Active artificial intelligence dealmaking activity since 2014

                                                                                                                          Figure 3: Artificial intelligence partnering by deal type since 2014

                                                                                                                            Figure 4: Artificial intelligence partnering by disease type since 2014

                                                                                                                              Figure 5: Artificial intelligence deals with a headline value

                                                                                                                                Figure 6: Artificial intelligence deals with an upfront value

                                                                                                                                  Figure 7: Artificial intelligence deals with a milestone value

                                                                                                                                    Figure 8: Artificial intelligence deals with a royalty rate value

                                                                                                                                      Figure 9: Top artificial intelligence deals by value since 2014

                                                                                                                                        Figure 10: Most active artificial intelligence dealmakers since 2014

                                                                                                                                          Figure 11: Online partnering resources

                                                                                                                                            Figure 12: Forthcoming partnering events

                                                                                                                                            The Global Artificial Intelligence Partnering Agreements 2014-2019 report provides an understanding and access to the artificial intelligence partnering deals and agreements entered into by the worlds leading healthcare companies.

                                                                                                                                            Trends in artificial intelligence partnering deals

                                                                                                                                            Disclosed headlines, upfronts, milestones and royalties by stage of development

                                                                                                                                            Artificial intelligencepartnering contract documents

                                                                                                                                            Top artificial intelligence deals by value



                                                                                                                                            The Global Artificial Intelligence Partnering Terms and Agreements 2014-2019 report provides an understanding and access to the artificial intelligence partnering deals and agreements entered into by the worlds leading healthcare companies.

                                                                                                                                            The report provides a detailed understanding and analysis of how and why companies enter artificial intelligencepartnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors artificial intelligencetechnology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

                                                                                                                                            This report provides details of the latest artificial intelligence, oligonucletides including aptamers agreements announced in the healthcare sectors. 

                                                                                                                                            Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not.

                                                                                                                                            This report contains a comprehensive listing of all artificial intelligence partnering deals announced since 2014 including financial terms where available including over 200 links to online deal records of actual artificial intelligence partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

                                                                                                                                            Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

                                                                                                                                            For example, analyzing actual company deals and agreements allows assessment of the following:

                                                                                                                                            What is actually granted by the agreement to the partner company?

                                                                                                                                            What exclusivity is granted?

                                                                                                                                            What are the precise rights granted or optioned?

                                                                                                                                            What is the payment structure for the deal?

                                                                                                                                            How aresalesand payments audited?

                                                                                                                                            What is the deal term?

                                                                                                                                            How are the key terms of the agreement defined?

                                                                                                                                            How are IPRs handled and owned?

                                                                                                                                            Who is responsible for commercialization?

                                                                                                                                            Who is responsible for development, supply, and manufacture?

                                                                                                                                            How is confidentiality and publication managed?

                                                                                                                                            How are disputes to be resolved?

                                                                                                                                            Under what conditions can the deal be terminated?

                                                                                                                                            What happens when there is a change of ownership?

                                                                                                                                            What sublicensing and subcontracting provisions have been agreed?

                                                                                                                                            Which boilerplate clauses does the company insist upon?

                                                                                                                                            Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

                                                                                                                                            Which jurisdiction does the company insist upon for agreement law?



                                                                                                                                            The initial chapters of this report provide an orientation of artificial intelligence dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in artificial intelligence dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.

                                                                                                                                            Chapter 3 provides a review of the leading artificial intelligence deals since 2014. Deals are listed by headline value, signed by big pharma, most active artificial intelligence dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

                                                                                                                                            Chapter 4 provides a comprehensive listing of the top 25 most active companies in artificial intelligence dealmaking with a brief summary followed by a comprehensive listing of artificial intelligence deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

                                                                                                                                            Chapter 5 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan to 2014, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

                                                                                                                                            Chapter 6 lists artificial intelligence deals by technology type.

                                                                                                                                            Chapter 7 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan to 2014. The chapter is organized by specific artificial intelligence technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

                                                                                                                                            In addition, a comprehensive appendix is provided organized by artificial intelligence partnering company A-Z, deal type definitions and artificial intelligence partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

                                                                                                                                            The report also includes numerous tables and figures that illustrate the trends and activities in artificial intelligence partnering and dealmaking since 2014.

                                                                                                                                            In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of artificial intelligence technologies and products.

                                                                                                                                            Report scope

                                                                                                                                            Global Artificial Intelligence Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to artificial intelligence trends and structure of deals entered into by leading companies worldwide.

                                                                                                                                            Global Artificial Intelligence Partnering Terms and Agreements includes:

                                                                                                                                            Trends in artificial intelligence dealmaking in the biopharma industry since 2014

                                                                                                                                            Analysis of artificial intelligence deal structure

                                                                                                                                            Access to headline, upfront, milestone and royalty data

                                                                                                                                            Case studies of real-life artificial intelligence deals

                                                                                                                                            Access to over 200 artificial intelligence deals

                                                                                                                                            The leading artificial intelligence deals by value since 2014

                                                                                                                                            Most active artificial intelligence dealmakers since 2014

                                                                                                                                            The leading artificial intelligence partnering resources



                                                                                                                                            In Global Artificial Intelligence Partnering Terms and Agreements, the available contracts are listed by:

                                                                                                                                            Company A-Z

                                                                                                                                            Headline value

                                                                                                                                            Stage of development at signing

                                                                                                                                            Deal component type

                                                                                                                                            Specific therapy and technology target


                                                                                                                                            Summary:
                                                                                                                                            Get latest Market Research Reports on Artificial Intelligence (AI) Partnering. Industry analysis & Market Report on Artificial Intelligence (AI) Partnering is a syndicated market report, published as Global Artificial Intelligence (AI) Partnering 2019 to 2024. It is complete Research Study and Industry Analysis of Artificial Intelligence (AI) Partnering market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                                                                                            Purchase this Report

                                                                                                                                            $3,200.00
                                                                                                                                            $6,400.00
                                                                                                                                            2,568.85
                                                                                                                                            5,137.71
                                                                                                                                            2,848.32
                                                                                                                                            5,696.64
                                                                                                                                            345,756.80
                                                                                                                                            691,513.60
                                                                                                                                            219,655.04
                                                                                                                                            439,310.08
                                                                                                                                            Credit card Logo

                                                                                                                                            Related Reports


                                                                                                                                            Reason to Buy

                                                                                                                                            Request for Sample of this report